Impact of fluoroquinolone prophylaxis on bloodstream infection incidence after allogeneic stem cell transplantation

被引：0
|
作者：
Dellacasa, Chiara Maria [1 ]
Giaccone, Luisa [1 ]
Butera, Sara [1 ]
Santambrogio, Elisa [1 ]
Passera, Roberto [1 ]
Aydin, Semra [1 ]
Brunello, Lucia [1 ]
Faraci, Danilo [1 ]
Frairia, Chiara [1 ]
Iovino, Giorgia [1 ]
Manetta, Sara [1 ]
Bruno, Benedetto [1 ]
Busca, Alessandro [1 ]
机构：
[1] AOU Citta Salute & Sci Torino, Turin, Italy
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P410
引用
收藏
页码：409 / 410
页数：2
相关论文
共 50 条
  • [31] Extension of CMV prophylaxis possible after allogeneic stem cell transplantation
    Freyer, Martina
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (04) : 162 - 162
  • [32] Delayed ABLC prophylaxis after allogeneic stem-cell transplantation
    Jansen, Jan
    Akard, Luke P.
    Wack, Matthew F.
    Thompson, James M.
    Dugan, Michael J.
    Leslie, Jill K.
    Mattison, Reid
    MYCOSES, 2006, 49 (05) : 397 - 404
  • [33] Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation
    Mendorf, Alexander
    Klyuchnikov, Evgeny
    Langebrake, Claudia
    Rohde, Holger
    Ayuk, Francis
    Regier, Marc
    Christopeit, Maximilian
    Zabelina, Tatjana
    Bacher, Adelbert
    Stuebig, Thomas
    Wolschke, Christine
    Bacher, Ulrike
    Kroeger, Nicolaus
    ACTA HAEMATOLOGICA, 2015, 134 (03) : 146 - 154
  • [34] Extension of CMV Prophylaxis possible after allogeneic Stem Cell Transplantation
    Freyer, Martina
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (02) : 127 - 127
  • [35] Impact of Fluoroquinolone Prophylaxis on Survival Outcomes after Hematopoietic Stem Cell Transplantation: A Single-Center Experience
    Jacobson, Stephanie
    Clemmons, Amber Bradley
    Shah, Arpita
    Albrecht, Benjamin
    Sportes, Claude
    Biyan, Locke
    Pantin, Jeremy
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S167 - S168
  • [36] Impact of prophylaxis regimen on the incidence of acute graft-versus-host disease after allogeneic blood stem cell transplantation.
    Przepiorka, D
    Ippoliti, C
    Khouri, I
    Anderlini, P
    Folloder, J
    Ueno, N
    Mehra, R
    Giralt, S
    Gajewski, J
    Cleary, K
    Claxton, D
    Champlin, R
    Andersson, B
    Körbling, M
    BONE MARROW TRANSPLANTATION, 1998, 21 : S107 - S107
  • [37] Levofloxacin Based Prophylaxis in Children Receiving Allogeneic Hematopoietic Stem Cell Transplantation Does not Affect the Incidence of Acute GVHD and Bloodstream Infections
    Leardini, Davide
    Zama, Daniele
    Muratore, Edoardo
    Tozzi, Andrea
    Papaleo, Teresa
    Bacelli, Francesco
    Belotti, Tamara
    Legnani, Elena
    Prete, Arcangelo
    Pession, Andrea
    Masetti, Riccardo
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 654 - 655
  • [38] IMPACT OF LEVOFLOXACIN PROPHYLAXIS WITHDRAWAL ON PRE-ENGRAFTMENT BLOODSTREAM INFECTIONS AFTER AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANT
    Clerici, D.
    Oltolini, C.
    Greco, R.
    Erbella, F.
    Nitti, R.
    Lugli, A.
    Ripa, M.
    Giglio, F.
    Mastaglio, S.
    Lorentino, F.
    Farina, F.
    Liberatore, C.
    Castiglioni, B.
    Din, C. Tassan
    Bernardi, M.
    Peccatori, J.
    Corti, C.
    Scarpellini, P.
    Castagna, A.
    Ciceri, F.
    HAEMATOLOGICA, 2021, 106 (10) : 47 - 47
  • [39] Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation
    F Schlemmer
    M Lagrange-Xélot
    C Lacroix
    R de La Tour
    G Socié
    J-M Molina
    Bone Marrow Transplantation, 2008, 42 : 551 - 552
  • [40] Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation
    Schlemmer, F.
    Lagrange-Xelot, M.
    Lacroix, C.
    de La Tour, R.
    Socie, G.
    Molina, J-M
    BONE MARROW TRANSPLANTATION, 2008, 42 (08) : 551 - 552
12345